Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide. (3rd May 2020) - Alghazali, Mohammed; Löfgren, Annica; Cheng, Newton; Fagerlund, Karin; Bjartell, Anders